<DOC>
	<DOCNO>NCT02817685</DOCNO>
	<brief_summary>This study randomize control prospective study . The aim study establish all-round convenient follow-up strategy Chronic Hepatitis B early detection diagnosis Hepatocellular Carcinoma ( HCC ) , investigate whether different surveillance time interval surveillance method beneficial chronic hepatitis B cirrhotic patient different risk HCC .</brief_summary>
	<brief_title>Follow-up Strategy Chronic Hepatitis B Early Detection Diagnosis Hepatocellular Carcinoma : A Randomized Control Trial</brief_title>
	<detailed_description>Surveillance chronic hepatitis B cirrhotic patient demonstrate increase chance curative treatment hepatocellular carcinoma . However , optimal surveillance interval different risk patient still controversial . The AASLD EASL-EORTC guideline recommend chronic hepatitis B patient undergo ultrasound surveillance time interval 6 month , Japanese HCC guideline recommend very-high risk patient undergo ultrasound surveillance time interval 3 4 month . The incidence HCC 0.3 % -0.8 % chronic hepatitis B patient 2 % -8 % cirrhotic patient , thus recall different follow-up strategy different stage chronic hepatitis B patient . Besides , ultrasound admit surveillance tool HCC convenience cost-effectiveness . However , sensitivity ultrasound detect HCC remarkably decrease influence rib , pulmonary gastrointestinal gas , cirrhosis fatty liver . So necessary incorporate compute tomography ( CT ) magnetic resonance imaging ( MRI ) follow-up strategy high risk patient patient cirrhosis history HCC . The aim study investigate whether different surveillance time interval surveillance method beneficial chronic hepatitis B cirrhotic patient different risk HCC , ultimately establish all-round convenient follow-up strategy Chronic Hepatitis B early detection diagnosis HCC .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<criteria>1 . HBVAg positive ( ï¼ž6 month ) 2. age among 18 80 year 1. patient hepatocellular carcinoma 2. patient diagnosis hepatocellular carcinoma within 3 month inclusion ; 3. patient alcoholic hepatitis autoimmune hepatitis 4. patient severe uncontrolled disease result estimate life expectance less 1 year 5. coinfection human immunodeficiency virus ( HIV ) 6. undergo contrastenhanced image 7. refuse attending study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>surveillance</keyword>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>ultrasound</keyword>
	<keyword>cirrhosis</keyword>
	<keyword>chronic hepatitis B</keyword>
</DOC>